Skip to main content
Journal cover image

Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.

Publication ,  Journal Article
Bergin, SP; Chemaly, RF; Dadwal, SS; Hill, JA; Lee, YJ; Haidar, G; Luk, A; Drelick, A; Chin-Hong, PV; Benamu, E; Khawaja, F; Nanayakkara, D ...
Published in: Clin Infect Dis
March 20, 2024

BACKGROUND: Pneumonia is a common cause of morbidity and mortality, yet a causative pathogen is identified in a minority of cases. Plasma microbial cell-free DNA sequencing may improve diagnostic yield in immunocompromised patients with pneumonia. METHODS: In this prospective, multicenter, observational study of immunocompromised adults undergoing bronchoscopy to establish a pneumonia etiology, plasma microbial cell-free DNA sequencing was compared to standardized usual care testing. Pneumonia etiology was adjudicated by a blinded independent committee. The primary outcome, additive diagnostic value, was assessed in the Per Protocol population (patients with complete testing results and no major protocol deviations) and defined as the percent of patients with an etiology of pneumonia exclusively identified by plasma microbial cell-free DNA sequencing. Clinical additive diagnostic value was assessed in the Per Protocol subgroup with negative usual care testing. RESULTS: Of 257 patients, 173 met Per Protocol criteria. A pneumonia etiology was identified by usual care in 52/173 (30.1%), plasma microbial cell-free DNA sequencing in 49/173 (28.3%) and the combination of both in 73/173 (42.2%) patients. Plasma microbial cell-free DNA sequencing exclusively identified an etiology of pneumonia in 21/173 patients (additive diagnostic value 12.1%, 95% confidence interval [CI], 7.7% to 18.0%, P < .001). In the Per Protocol subgroup with negative usual care testing, plasma microbial cell-free DNA sequencing identified a pneumonia etiology in 21/121 patients (clinical additive diagnostic value 17.4%, 95% CI, 11.1% to 25.3%). CONCLUSIONS: Non-invasive plasma microbial cell-free DNA sequencing significantly increased diagnostic yield in immunocompromised patients with pneumonia undergoing bronchoscopy and extensive microbiologic and molecular testing. CLINICAL TRIALS REGISTRATION: NCT04047719.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

March 20, 2024

Volume

78

Issue

3

Start / End Page

775 / 784

Location

United States

Related Subject Headings

  • Sequence Analysis, DNA
  • Prospective Studies
  • Pneumonia
  • Microbiology
  • Immunocompromised Host
  • Humans
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bergin, S. P., Chemaly, R. F., Dadwal, S. S., Hill, J. A., Lee, Y. J., Haidar, G., … Holland, T. L. (2024). Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis, 78(3), 775–784. https://doi.org/10.1093/cid/ciad599
Bergin, Stephen P., Roy F. Chemaly, Sanjeet S. Dadwal, Joshua A. Hill, Yeon Joo Lee, Ghady Haidar, Alfred Luk, et al. “Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.Clin Infect Dis 78, no. 3 (March 20, 2024): 775–84. https://doi.org/10.1093/cid/ciad599.
Bergin SP, Chemaly RF, Dadwal SS, Hill JA, Lee YJ, Haidar G, et al. Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis. 2024 Mar 20;78(3):775–84.
Bergin, Stephen P., et al. “Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.Clin Infect Dis, vol. 78, no. 3, Mar. 2024, pp. 775–84. Pubmed, doi:10.1093/cid/ciad599.
Bergin SP, Chemaly RF, Dadwal SS, Hill JA, Lee YJ, Haidar G, Luk A, Drelick A, Chin-Hong PV, Benamu E, Khawaja F, Nanayakkara D, Papanicolaou GA, Small CB, Fung M, Barron MA, Davis T, McClain MT, Maziarz EK, Madut DB, Bedoya AD, Gilstrap DL, Todd JL, Barkauskas CE, Bigelow R, Leimberger JD, Tsalik EL, Wolf O, Mughar M, Hollemon D, Duttagupta R, Lupu DS, Bercovici S, Perkins BA, Blauwkamp TA, Fowler VG, Holland TL. Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis. 2024 Mar 20;78(3):775–784.
Journal cover image

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

March 20, 2024

Volume

78

Issue

3

Start / End Page

775 / 784

Location

United States

Related Subject Headings

  • Sequence Analysis, DNA
  • Prospective Studies
  • Pneumonia
  • Microbiology
  • Immunocompromised Host
  • Humans
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences